Polymyositis Initiation Involving Amlodipine Besylate
R. M. Golding, L. G.F. Giles and E. M. Sokoya
DOI : 10.3844/ajisp.2006.19.22
American Journal of Immunology
Volume 2, Issue 1
Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular patient was initiated by taking the drug amlodipine besylate (norvasc). The method of our analysis should serve as a foundation in handling other drug related interactions.
© 2006 R. M. Golding, L. G.F. Giles and E. M. Sokoya. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.